We aimed at addressing the function of γδ T cells and their chemoattraction via CCL-20 in our CAC model by injecting anti-γδTCR at day 3 of the 1.5% AOM/DSS protocol prior to the colitis phase of CAC into control and IL-6Rα-deficient animals. Here, IL6R is linked to infectious otitis media.